Health
Genetic test identifies invasive lobular carcinomas that are at high risk of recurring – Medical Xpress
New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is …
New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
Adjuvant treatments, such as chemotherapy, radiation therapy or targeted therapies, are not usually offered to ILC patients after surgery as the disease is slow growing and often responds well to hor…
-
General17 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Noosa News21 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
Noosa News21 hours ago$20 million program to help women return to work
-
General18 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire